Expanded Access for CC-2001
Overview
This is an expanded access program (EAP) for eligible participants designed to provide access to CC-2001.
Study Type
- Study Type: Expanded Access
Interventions
- Drug: CC-2001
- CC-2001 will be administered orally
Participating in This Clinical Trial
Inclusion Criteria
- Exclusion Criteria:
-
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Investigator Details
- Lead Sponsor
- Celgene
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.